Skip to main content
S 1681 115th Congress Senate Health Drug safety, medical device, and laboratory regulation Health programs administration and funding Health technology, devices, supplies Inflation and prices Intellectual property Medical research Research and development

A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.

Introduced: July 31, 2017 Introduced by: Sanders, Bernard Independent · Vermont See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 31, 2017
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jul 31, 2017
Introduced in Senate
 Plain-English summary Congressional Research Service

This bill prohibits federal agencies and nonprofit entities that conduct federally funded health care research from providing a patent for a drug based on such research until the entity receiving the patent enters into a reasonable pricing agreement with the Department of Health and Human Services.

What's happening now July 31, 2017

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Committees of jurisdiction 1